Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Vázquez-Pérez, S.
Right arrow Articles by Cachofeiro, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vázquez-Pérez, S.
Right arrow Articles by Cachofeiro, V.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2001) 16: 40-44
© 2001 European Renal Association-European Dialysis and Transplant Association

Atorvastatin prevents glomerulosclerosis and renal endothelial dysfunction in hypercholesterolaemic rabbits

Sandra Vázquez-Pérez, Paloma Aragoncillo1, Natalia de las Heras, Josefa Navarro-Cid, Eva Cediel, David Sanz-Rosa, Luis Miguel Ruilope2, Cristina Díaz3, Gonzalo Hernández3, Vicente Lahera and Victoria Cachofeiro

Physiology Department, School of Medicine, Universidad Complutense, 1 Pathology Department, Unit II, Hospital Clínico San Carlos, 2 Hypertension Unit, Hospital 12 de Octubre, Madrid and 3 Parke Davis R&D Department, Barcelona, Spain

Background. Numerous studies have shown that elevated plasma cholesterol can exacerbate renal disease. However, the effect of lipids on renal structure and vascular function in normal kidneys is less well established. Therefore, the aim of this study was to evaluate the impact of hypercholesterolaemia on glomerular structure and vascular reactivity of segmental arteries in rabbits. In addition, we also studied whether or not atorvastatin can prevent these structural and vascular alterations in hypercholesterolaemic rabbits.

Methods. Male New Zealand rabbits were fed either a normal rabbit chow or a diet containing 1% cholesterol and treated or not with atorvastatin (1 mg/kg/day) for 12 weeks. Dose–response curves to acetylcholine (10-9–10-4 mol/l) and sodium nitroprusside (10-9–10-4 mol/l) were studied in segmental arteries in the presence or absence of the thromboxane A2/PGH2 receptor antagonist ifetroban (10-5 mol/l). Glomerular size and structure were also evaluated.

Results. Compared with control animals, hypercholesterolaemic rabbits presented glomerular hypertrophy and several types of injuries (capillary collapse, hyalinosis and alterations of Bowman's capsule), suggesting diffuse glomerulosclerosis. Segmental arteries also showed relaxing responses to acetylcholine and sodium nitroprusside which were lower than and similar to, respectively, those of control animals. The presence of ifetroban improved the acetylcholine response only in hypercholesterolaemic rabbits. Atorvastatin treatment prevented vascular and most glomerular changes associated with hypercholesterolaemia even in the presence of very high cholesterol levels.

Conclusions. Atorvastatin exerts a protective effect on renal damage associated with hypercholesterolaemia even in the presence of deleterious levels of plasma cholesterol.

Keywords: atorvastatin; endothelial function; glomerular hypertrophy; glomerulosclerosis; hypercholesterolaemia

Correspondence and offprint requests to: V. Cachofeiro, Departamento de Fisiología, Facultad de Medicina, Universidad Complutense, Madrid 28040, Spain.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Mayo Clin Proc.Home page
R. Agarwal
Effects of Statins on Renal Function
Mayo Clin. Proc., November 1, 2007; 82(11): 1381 - 1390.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
N. D. Vaziri
Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences
Am J Physiol Renal Physiol, February 1, 2006; 290(2): F262 - F272.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.